2. Search Result
Search Result
Results for "

LDD39

" in MedChemExpress (MCE) Product Catalog:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-159967
    LDD39

    		PROTACs RET Cancer
    LDD39 is a PROTAC targeting RET protein, capable of achieving robust and sustained degradation of total RET (tRET) protein in vivo and inhibiting phosphorylated RET (pRET) signaling. LDD39 is formed by conjugating an E3 ligase ligand (HY-170371) and a target protein ligand (HY-170373) through a linker (HY-30105) (E3 ligase ligand＋Linker: HY-170374) .
    LDD39

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: